Minutes - Medication WG 2021-05-11

Attendees

• Bruno Casneuf
• Dieter Sauvillers
• Elhassan Baazizi
• Hanne Vuegen
• Jean-Louis Maggetto
• Jean-Michel Polfliet
• Jens Penny
• José Costa Teixeira
• Karlien Erauw
• Pablo Christiaens
• Richard Francken
• Robin Bosman
• Tom De Backer
• Tom Henkens
• Will van Norel

Excused/Not present

• Anne Nerenhausen
• Annemieke Vergauwe
• Jan Lenie
• Jeroen De Wilde
• Lars Vanreppelen
• Marc Buckens
• Nils Devos

Agenda

• feedback on the model

Minutes

• Magistral preparations: no update
• What is the purpose and intent of the high level modelling towards the scope of the medication scheme project and exchange of the related MS information, including the outcome

• the purpose of the logical model is having a common understanding what the data means apart from the FHIR modelling
• logical model is perceived as a flow

• What do we want to achieve here ? the MS, the careplan, ...

• the purpose is to achieve the MS
• are we going to translate kmehr to FHIR ? lots of risks
• starting from something completely new: we risk to lose data fromo the past

can the care plan be left out from this WG ?

• We miss the definition of the MS

• currently the MS in kmehr is visualised in a document

---

*

• Definitions related to Medication Scheme: http://build.fhir.org/ig/hl7-be/riziv-medication-record/toc.html

• not updated on https://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/medicationrecord-definitions.html yet
• treatment item is now treatment line
• treatment is not about allergies, is what the doctor prescribes, can be updated by someone else (optional)
• treatment consists of treatment lines
• treatment lines: do we split this by indication ? TBC
• treatment summary: will have lines but different lines, different from what one doctor intended
• patient can have different treatments, a treatment can be updated by different doctors
• Medication summary can be constructed by a system or by a person
• Medication Record has all the data related to usage of medication of a person
• who owns the treatment line ? the doctor but it can be updated by other doctors
• an indication might be linked to a treatment, it is not mandatory: none to multiple indications are possible
• use of word treatment is not correct in its scientific way but is linked to the usage of a medication
• How does het Medication Scheme fit here ? José is showing data model of medication record: http://build.fhir.org/ig/hl7-be/riziv-medication-record/medicationrecord-data-model.html

• use case #1: http://build.fhir.org/ig/hl7-be/riziv-medication-record/medicationrecord-scenario-1.html : a medication for 3 different indications ; what does the summary have to show ? is this 3 or 1 treatments ?

• José is showing the FHIR resources: http://build.fhir.org/ig/hl7-be/riziv-medication-record/medicationrecord-fhir-resources.html

• Usage statement: here patient can indicate that he doesn't take the medication or that he only takes half of the dose

• Remark: the current implementation of the medication scheme is less complex but causes already plenty of issues in the field
• Question: do we need 1 central repository ? No, to be discussed in detail next meeting

Action items for next meeting

• each one of us to check offline and with his team to continue discussion on treatment lines

Next meeting May 11 at 11AM